World Nanobiotechnology Market

Table of Contents

• 1. Executive Summary
  • 1. Executive Summary
    • 1. Executive Summary
• 2. Introduction to Nanobiotechnology
  • 1. Introduction to Nanobiotechnology
    • 1. Nanobiotechnology - An Overview
    • 2. Key Materials Involved in Nanobiotechnology
    • 3. Nanomaterial Applications in Nanobiotechnology
    • 4. Nanoemulsion Milling as an Enabling Technology
• 3. Nanobiotechnology Market Overview
  • 1. Market Breakup
    • 1. Analysis Assumptions
    • 2. Geographical Breakup of the Nanobiotechnology Sector
    • 3. World Infrastructure of the Nanobiotechnology Sector
    • 4. Regulatory Affairs in Nanobiotechnology
• 4. Nanobiotechnology Market Trends
  • 1. Trends in the Nanobiotechnology Market
    • 1. Industry Challenges
      • a. Well Developed Competing Technologies
      • b. Nanobiotechnology Manufacturing Costs
      • c. Lack of Manufacturing Standardisation
      • d. Lack of Volumetric Demand for Nanobiotechnology Materials
      • e. Lack of Standardised Nomenclature for Manufactured Nanoparticles
      • f. Potential Safety Issues and Lack of Safety Legislation
      • g. Pressure from Nongovernmental Organisations (NGOs) for Enhanced Safety Testing
      • h. Complex European Registration Process for New Therapeutic Products
    • 2. Industry Challenge Timeframe Analysis
    • 3. Market Drivers
      • a. Significant Levels of Public and Private Funding Available for Nanobiotechnology Innovation
      • b. Increase in Pharmaceutical Generics Drives a Need for New Formulations
      • c. Innovation is Required for the Treating Areas of Unmet medical Need and for Sustaining the Pipelines of Pharmaceutical Companies
      • d. Emergence of First Products Onto the Market
    • 4. Market Restraints
      • a. Expense and Availability of Nanomaterials
      • b. More is Expected from the Nanotechnology Sector Than Can be Provided
      • c. Lack of Information on Safety Nanomaterial Safety and Environmental Fate Influences Public Perception
      • d. Lack of Funding and Human Resource Allocation Into the Nanobiotechnology Sector from Big Pharmaceutical Firms
    • 5. Market Engineering Measurements
    • 6. Revenue Forecasts
• 5. Nanomaterials in Nanobiotechnology
  • 1. Introduction to Nanomaterials
    • 1. Nanomaterials
  • 2. Market Trends in Dendrimer Manufacture
    • 1. Market Engineering Measurements
    • 2. Revenue Forecast
    • 3. Dendrimer Pricing Analysis
    • 4. Market Participants in Dendrimer Manufacture
  • 3. Market Trends in Nanoparticle Manufacture
    • 1. Market Engineering Measurements
    • 2. Revenue Forecast
    • 3. Nanoparticle Pricing Analysis
    • 4. Market Participants in Nanoparticle Manufacture
  • 4. Market Trends in Fullerene and Nanotube Manufacture
    • 1. Market Engineering Measurements
    • 2. Revenue Forecast
    • 3. Fullerene and Nanotube Pricing Analysis
    • 4. Market Participants in Fullerene and Nanotube Manufacture
• 6. Nanobiotechnology Applications
  • 1. Nanobiotechnology Applications
    • 1. Introduction to Nanobiotechnology Applications
    • 2. Nanobiotechnology Product Pipeline
  • 2. Competitive Analysis - Therapeutics
    • 1. Competitive Analysis - Therapeutics
    • 2. Market Participants
    • 3. Academic Research
    • 4. Other Key Industry Participants
  • 3. Competitive Analysis - Drug Delivery
    • 1. Competitive Analysis - Drug Delivery
    • 2. Market Leaders
    • 3. Academic Research
    • 4. Other Key Industry Participants
  • 4. Competitive Analysis - Tissue Reconstruction
    • 1. Competitive Analysis - Tissue Reconstruction
    • 2. Market Leaders
    • 3. Academic Research
• 7. Market Engineering Strategy for the World Nanobiotechnology Market
  • 1. Market Engineering Strategy
    • 1. Introduction to Strategic Recommendations
    • 2. Market Maturation Process
    • 3. Strategic Anticipation
• 8. Frost & Sullivan Awards
  • 1. Frost & Sullivan Awards
    • 1. Introduction to Frost & Sullivan Awards
    • 2. Frost & Sullivan Market Leadership Award
    • 3. Frost & Sullivan Growth Strategy Leadership Award
    • 4. Frost & Sullivan Product Differentiation Innovation Award
    • 5. Frost & Sullivan Technology Leadership Award
    • 6. Frost & Sullivan Entrepreneurial Company Award
• 9. Decision Support Databases
  • 1. Decision Support Databases
    • 1. Number of Biotechnology Companies (1999-2006)
    • 2. Biotechnology Private Investment (1999-2006)
    • 3. Government Investment in Biotechnology (1999-2006)
    • 4. Total Healthcare Expenditure (1999-2006)